<DOC>
	<DOCNO>NCT00921791</DOCNO>
	<brief_summary>High blood pressure main risk factor cardiovascular disease worldwide , control rate unsatisfactory . Home Blood Pressure Monitoring ( HBPM ) automatic oscillometric device pharmaceutical care propose intervention increase therapeutic compliance guide treatment decision . The purpose study evaluate effect HBPM pharmaceutical care blood pressure control measure 24h ambulatory blood pressure monitoring ( ABPM ) .</brief_summary>
	<brief_title>Efficacy Home Blood Pressure Monitoring ( MONITOR Study )</brief_title>
	<detailed_description>Home Blood Pressure Monitoring ( HBPM ) Pharmaceutical care propose improve therapeutic compliance guide treatment decision , effect BP control still debate . This factorial randomized control trial include adult hypertensive patient drug treatment office BP 24h ABPM uncontrolled . Participants allocate one four group : HBPM ; HBPM Pharmaceutical care ; Pharmaceutical care ; control . All participant receive usual care high blood pressure . Participants follow 60 day .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>Office BP ≥140/90 mm Hg 24h ABPM hypertension BP ≥130/80 mm Hg use least one antihypertensive drug BP ≥ 180 / 110 mmHg ) major cardiovascular event last six month acute chronic disease limit capacity understand participate trial masked hypertension whitecoat hypertension secondary hypertension pregnancy breastfeed concurrent participation another trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Blood pressure</keyword>
	<keyword>Home Blood Pressure Monitoring</keyword>
	<keyword>Ambulatory Blood Pressure Monitoring</keyword>
	<keyword>Pharmaceutical care</keyword>
</DOC>